Skip to content

Contingency Management for Smoking Cessation

Randomized Trial of a Contingency Management Smoking Cessation Intervention for Homeless Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04982952
Enrollment
83
Registered
2021-07-29
Start date
2021-11-09
Completion date
2024-06-30
Last updated
2024-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation, Smoking Reduction, Smoking, Tobacco

Keywords

Contingency Management

Brief summary

The prevalence of smoking in the homeless population (70%) is over 4 times that of the general population (15%). Homeless adults have not experienced similar declines in tobacco use as the general population has over the past three decades. Homeless adults are interested in smoking cessation and make quit attempts, but are less successful in quitting smoking than the general population. Trials of group behavioral counseling and pharmacotherapy for smoking cessation have not led to substantial long-term abstinence (i.e., abstinence for 6 months or more), suggesting that these interventions alone are insufficient to improve quit rates among homeless adults. Many homeless adults seek health care in safety net clinics; these clinics could bring cessation interventions to scale. Contingency management is a powerful behavior change intervention that reinforces positive health behaviors through the provision of modest incentives (e.g., cash). In this pilot randomized controlled trial, the investigator will test the feasibility and acceptability of a contingency management intervention that provides incentives for smoking cessation for people experiencing homelessness.

Detailed description

In this pilot randomized controlled trial (RCT), the investigator will (1) adapt a known-efficacious extended CM cessation intervention to a novel population and setting, with the ultimate goal of increasing long-term abstinence among homeless adults seeking care in safety net health clinics, (2) develop a corresponding RCT protocol, and (3) conduct a pilot RCT to assess the feasibility and acceptability of the RCT. If the pilot RCT is feasible and acceptable, the investigator will test the adapted intervention in a subsequently-funded, full-scale RCT. Primary Objectives: Assess feasibility and acceptability of a CM intervention through: 1. Measuring biochemically-verified point prevalence abstinence at 6 months follow-up. 2. Measuring participant adherence to the protocol. 3. Gathering information on the number of visits attended. 4. Assessing the retention protocol. Secondary Objectives Assess feasibility and acceptability of a CM intervention through: 1. Biochemically-verified 7-day point months follow-up at 3 months. 2. Prolonged abstinence at 3 months and 6 months follow-up. 3. Point-prevalent abstinence at 12 months

Interventions

BEHAVIORALContingency Management - Increasing

Increasing incentive payment for abstinent participant

BEHAVIORALFixed payments

Fixed payments for attending study visits

Sponsors

Tobacco Related Disease Research Program
CollaboratorOTHER
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Randomization into one of 2 groups will be stratified by recruiter and a binary nicotine dependency code

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Are 18 years or older 2. Engaged in care at the Tom Waddell Urban Health Center (TWUHC) 3. Meet criteria for homelessness as defined by the Homeless Emergency Assistance and Rapid Transition to Housing Act 4. Are current smokers (smoked at least 100 cigarettes in lifetime, smoked daily in the past 7 days and at least 5 cigarettes per day, verified by expired Carbon Monoxide (CO) \>= 8 parts per million (ppm)) 5. Have an intention to quit smoking within the next six months 6. Are attending on-site smoking cessation counseling provided by the behavioral counselors 7. Are English proficient 8. Are able to provide informed consent. Patients who are interested in participating but not enrolled in counseling services will be encouraged to engage in counseling sessions at the time of enrollment.

Exclusion criteria

1\. Are unable to take nicotine replacement therapy (e.g., pregnancy or myocardial infarction (MI) within the past 2 weeks)

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants who achieve point prevalence abstinence6 monthsThe proportion of participants who achieve biochemically-verified 7-day point prevalence abstinence defined as participants (1) reporting not smoking a single cigarette in the past seven days, not even a puff; (2) having carbon monoxide (CO) levels \<=5 parts per million (ppm), and (3) urinary anatabine/anabasine assay levels \< 2 nanograms per milliliter (ng/ml).
Median number of carbon monoxide (CO) negative samples6 monthsThe total number of negative CO specimen samples collected throughout the first 6 months of the program will be reported with 24 maximum possible number of samples per person.
Median total number of counseling sessions attended6 monthsThe number of counseling sessions attended per person will will recorded with a maximum of 5 sessions total.
Proportion of the sample retained as a result of retention procedures over timeUp to 12 monthsThe proportion of participants who choose to attend cessation sessions visits at 2 weeks, 1 month, 3 months, 6 months, and 12 months. A participant will be considered lost to follow-up and censored on their last visits if the participants have failed to return for a scheduled visit and the study staff are unable to contact the participant after at least 3 attempts.

Secondary

MeasureTime frameDescription
Proportion of participants who achieve point prevalence abstinence3 monthsThe proportion of participants who achieve biochemically-verified 7-day point prevalence abstinence defined as participants (1) reporting not smoking a single cigarette in the past seven days, not even a puff; (2) having carbon monoxide (CO) levels \<=5 parts per million (ppm)
Proportion of participants who achieve prolonged abstinence over timeUp to 6 monthsProlonged abstinence is defined as participants (1) not smoking a single cigarette since the last visit; (2) having CO levels \<=5 ppm

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 13, 2026